In a recent article, Kaido et al. reported that sarcopenia was linked to increased
posttransplant mortality in individuals undergoing living donor liver transplantation (1). The
findings are considered highly important because accumulating knowledge on sarcopenia
indicates that this condition may be associated with adverse outcomes in a wide range of
clinical conditions, including posttransplant survival. However, we needed to point on some
methodological issues regarding correct diagnosis of sarcopenia which is important …